JDMF 306MF10119 of Farmak, A. S. | Japan Drug Master Files | JP DMF | Pharmacompass.com

Please Wait

Applying Filters...

FARMAK, A.s

FARMAK, a.s

VIRTUAL BOOTH, Contact Details

DIGITAL CONTENT

7 Corporate Content #SupplierSpotlight, 25 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

28 All APIs, 8 USDMF, 5 CEP/COS, 5 JDMF, 10 KDMF, 2 NDC API, 22 Listed APIs

FINISHED DOSAGE FORMULATIONS

6 FDF Dossiers, 6 Europe

KEY PRODUCTS

Alfuzosin Hydrochloride, Brimonidine Tartrate, Bromfenac Sodium, Dofetilide, Eszopiclone, Moxonidine, Regadenoson Monohydrate, Riluzole, Tafamidis, Tafamidis Meglumine, Tizanidine Hydrochloride, Zolpidem Tartrate

SERVICES

API Manufacturing, API & Drug Product Development

API Manufacturing
API & Drug Product Development
- 3 API Development

KEY SERVICES

GMP API Manufacturing, Kilolab & Small Scale API Manufacturing

INSPECTIONS & REGISTRATIONS

6 FDA, 17 EDQM, 1 GDUFA, 2 Others, 3 Third-Party Audit

Xls

Filters

Filters

FILTER :

filter Registrant Name Reset all filters

1 All

01 1FARMAK, a. s.

filter Classification Reset all filters

filter Country Reset all filters

List of Suppliers

Supplier Virtual Booth

price-trend

01

FARMAK, a. s.

CPhI South East Asia

Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

Contact Supplier

Contact Supplier

Digital Content

Bromfenac sodium

Registration Number : 306MF10119

Registrant's Address : Na vlcinci 16/3 Klasterni Hradisko 77900 Olomouc Czech Republic

Initial Date of Registration : 2024-09-03

Latest Date of Registration : 2024-09-03

Farmak Company Banner

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.